Glucose-lowering effects of semaglutide compared with dulaglutide using professional continuous glucose monitoring in outpatients with type 2 diabetes mellitus: a pilot study

被引:0
|
作者
Akira Kurozumi
Yosuke Okada
Momo Saitoh
Yoshiya Tanaka
机构
[1] University of Occupational and Environmental Health,First Department of Internal Medicine, School of Medicine
来源
Diabetology International | 2023年 / 14卷
关键词
Type 2 diabetes mellitus; Continuous glucose monitoring; Semaglutide; Dulaglutide;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:356 / 362
页数:6
相关论文
共 50 条
  • [1] Glucose-lowering effects of semaglutide compared with dulaglutide using professional continuous glucose monitoring in outpatients with type 2 diabetes mellitus: a pilot study
    Kurozumi, Akira
    Okada, Yosuke
    Saitoh, Momo
    Tanaka, Yoshiya
    [J]. DIABETOLOGY INTERNATIONAL, 2023, 14 (04) : 356 - 362
  • [2] Glucose-lowering effects of 7-day treatment with SGLT2 inhibitor confirmed by intermittently scanned continuous glucose monitoring in outpatients with type 1 diabetes. A pilot study
    Kurozumi, Akira
    Okada, Yosuke
    Tanaka, Yoshiya
    [J]. ENDOCRINE JOURNAL, 2021, 68 (03) : 361 - 369
  • [3] Durability of glucose-lowering effect of dulaglutide in patients with type 2 diabetes mellitus: A real-world data study
    Kim, Hwi Seung
    Cho, Yun Kyung
    Kim, Myung Jin
    Jung, Chang Hee
    Park, Joong-Yeol
    Lee, Woo Je
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [4] Glucose-lowering effects of sulfasalazine in type 2 diabetes
    Haas, RM
    Li, P
    Chu, JW
    [J]. DIABETES CARE, 2005, 28 (09) : 2238 - 2239
  • [5] The Feasibility of Continuous Glucose Monitoring in Youth with Type 2 Diabetes Mellitus: A Pilot Study
    Laroche, Allison
    Utzschneider, Kristina
    Pihoker, Catherine
    [J]. DIABETES, 2019, 68
  • [6] Haemostasiologic effects of various glucose-lowering medications in type 2 diabetes mellitus.
    Petrik, G. G.
    Pavlishchuk, S. A.
    [J]. CARDIOVASCULAR THERAPY AND PREVENTION, 2010, 9 (02): : 48 - 53
  • [7] Glucose-lowering medicines for type 2 diabetes
    Davoren, Peter
    [J]. AUSTRALIAN FAMILY PHYSICIAN, 2015, 44 (05) : 272 - 276
  • [8] Additive Postprandial Glucose-Lowering Effects of Mitiglinide and Sitagliptin in Patients with Type 2 Diabetes Mellitus
    Jung, Jin Ah
    Kaku, Kohei
    Kim, Jae Hyeon
    Kim, Jung-Ryul
    Ko, Jae-Wook
    Lee, Soo-Youn
    Huh, Wooseong
    [J]. ADVANCES IN THERAPY, 2013, 30 (11) : 1018 - 1029
  • [9] Additive Postprandial Glucose-Lowering Effects of Mitiglinide and Sitagliptin in Patients with Type 2 Diabetes Mellitus
    Jin Ah Jung
    Kohei Kaku
    Jae Hyeon Kim
    Jung-Ryul Kim
    Jae-Wook Ko
    Soo-Youn Lee
    Wooseong Huh
    [J]. Advances in Therapy, 2013, 30 : 1018 - 1029
  • [10] Second-line Glucose-Lowering Therapy in Type 2 Diabetes Mellitus
    Jung-Im Shin
    [J]. Current Diabetes Reports, 2019, 19